These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1355473)

  • 1. Benarthin: a new inhibitor of pyroglutamyl peptidase. III. Synthesis and structure-activity relationships.
    Hatsu M; Tuda M; Muraoka Y; Aoyagi T; Takeuchi T
    J Antibiot (Tokyo); 1992 Jul; 45(7):1088-95. PubMed ID: 1355473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benarthin: a new inhibitor of pyroglutamyl peptidase. II. Physico-chemical properties and structure determination.
    Hatsu M; Naganawa H; Aoyagi T; Takeuchi T
    J Antibiot (Tokyo); 1992 Jul; 45(7):1084-7. PubMed ID: 1355472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benarthin: a new inhibitor of pyroglutamyl peptidase. I. Taxonomy, fermentation, isolation and biological activities.
    Aoyagi T; Hatsu M; Kojima F; Hayashi C; Hamada M; Takeuchi T
    J Antibiot (Tokyo); 1992 Jul; 45(7):1079-83. PubMed ID: 1355471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of pyroglutamyl aminopeptidase by L-pyroglutamyl chloromethyl ketone.
    Fujiwara K; Kitagawa T; Tsuru D
    Biochim Biophys Acta; 1981 Mar; 658(1):10-6. PubMed ID: 6111350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrizinostatin: a new inhibitor of pyroglutamyl peptidase.
    Aoyagi T; Hatsu M; Imada C; Naganawa H; Okami Y; Takeuchi T
    J Antibiot (Tokyo); 1992 Nov; 45(11):1795-6. PubMed ID: 1361487
    [No Abstract]   [Full Text] [Related]  

  • 6. N-alpha-carbobenzoxy pyroglutamyl diazomethyl ketone as active-site-directed inhibitor for pyroglutamyl peptidase.
    Fujiwara K; Matsumoto E; Kitagawa T; Tsuru D
    Biochim Biophys Acta; 1982 Apr; 702(2):149-54. PubMed ID: 6123347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity studies with high-affinity inhibitors of pyroglutamyl-peptidase II.
    Kelly JA; Scalabrino GA; Slator GR; Cullen AA; Gilmer JF; Lloyd DG; Bennett GW; Bauer K; Tipton KF; Williams CH
    Biochem J; 2005 Jul; 389(Pt 2):569-76. PubMed ID: 15799721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-step synthesis of a pyroglutamyl peptidase inhibitor, pyrizinostatin, from an antibiotic, 2-methylfervenulone.
    Tatsuta K; Kitagawa M
    J Antibiot (Tokyo); 1994 Mar; 47(3):389-90. PubMed ID: 7909794
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of pyroglutamyl peptidase II synthesis by phorbol ester in the Y-79 retinoblastoma cell.
    Suen CS; Wilk S
    Endocrinology; 1991 Apr; 128(4):2169-74. PubMed ID: 1672274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase on TRH degradation in rat serum.
    Friedman TC; Wilk S
    Biochem Biophys Res Commun; 1985 Oct; 132(2):787-94. PubMed ID: 2865955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of a thyrotropin-releasing hormone-degrading enzyme in GH3 cells: induction of pyroglutamyl peptidase I by 3,5,3'-triiodothyronine.
    Suen CS; Wilk S
    Endocrinology; 1987 Aug; 121(2):770-5. PubMed ID: 2885183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyroglutamyl diazomethyl ketone: potent inhibitor of mammalian pyroglutamyl peptide hydrolase.
    Wilk S; Friedman TC; Kline TB
    Biochem Biophys Res Commun; 1985 Jul; 130(2):662-8. PubMed ID: 2862865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delineation of a particulate thyrotropin-releasing hormone-degrading enzyme in rat brain by the use of specific inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase.
    Friedman TC; Wilk S
    J Neurochem; 1986 Apr; 46(4):1231-9. PubMed ID: 2869108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid inactivation and phosphorylation of pyroglutamyl peptidase II in Y-79 human retinoblastoma cells after exposure to phorbol ester.
    Suen CS; Wilk S
    Endocrinology; 1990 Dec; 127(6):3038-46. PubMed ID: 1979029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prodrugs of peptides. IV: Bioreversible derivatization of the pyroglutamyl group by N-acylation and N-aminomethylation to effect protection against pyroglutamyl aminopeptidase.
    Bundgaard H; Møss J
    J Pharm Sci; 1989 Feb; 78(2):122-6. PubMed ID: 2565975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Oxoprolinal: transition-state aldehyde inhibitor of pyroglutamyl-peptide hydrolase.
    Friedman TC; Kline TB; Wilk S
    Biochemistry; 1985 Jul; 24(15):3907-13. PubMed ID: 2864952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium butyrate induces pyroglutamyl peptidase I and decreases thyrotropin-releasing hormone receptors in GH3 cells.
    Suen CS; Wilk S
    Endocrinology; 1989 Apr; 124(4):1654-60. PubMed ID: 2564336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the role of a pyroglutamyl peptidase, a post-proline cleaving enzyme and a post-proline dipeptidyl amino peptidase, each purified from the soluble fraction of guinea-pig brain, in the degradation of thyroliberin in vitro.
    Browne P; O'Cuinn G
    Eur J Biochem; 1983 Dec; 137(1-2):75-87. PubMed ID: 6140164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptobactin, a tricatechol-type siderophore from marine-derived Streptomyces sp. YM5-799.
    Matsuo Y; Kanoh K; Jang JH; Adachi K; Matsuda S; Miki O; Kato T; Shizuri Y
    J Nat Prod; 2011 Nov; 74(11):2371-6. PubMed ID: 22014204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of pyroglutamyl aminopeptidase by N alpha-carbobenzoxy-L-pyroglutamyl chloromethyl ketone.
    Fujiwara K; Matsumoto E; Kitagawa T; Tsuru D
    J Biochem; 1981 Aug; 90(2):433-7. PubMed ID: 6117551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.